Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
Joseph Therriault(Douglas Mental Health University Institute), Pedro Rosa‐Neto(Center for Diagnosis and Research on Alzheimer's Disease), Mira Chamoun(Douglas Mental Health University Institute), Nicholas J. Ashton(King's College London), Paolo Vitali(McGill University), Kaj Blennow(Sahlgrenska University Hospital), Juan Lantero‐Rodriguez(University of Gothenburg), Gassan Massarweh(McGill University), Jean‐Paul Soucy(Montreal Neurological Institute and Hospital), Serge Gauthier(Texas Instruments (France)), Andréa Lessa Benedet(University of Pittsburgh), Paramita Saha‐Chaudhuri(University of Vermont), Thomas K. Karikari(University of Pittsburgh), Peter Kunach(Southwestern Medical Center), Stijn Servaes(Douglas Mental Health University Institute), Firoza Z Lussier(McGill University), Cécile Tissot(Hirslanden Clinique des Grangettes), Henrik Zetterberg(University of Wisconsin–Madison), Gleb Bezgin(Montreal Neurological Institute and Hospital), Jaime Fernandez‐Arias(Douglas Mental Health University Institute), Tharick A. Pascoal(Montreal Neurological Institute and Hospital)
Cited by 300
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Situating the default-mode network along a principal gradient of macroscale cortical organization
|Proceedings of the National Academy of Sciences|2016|2.6k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k